Back to Search Start Over

18F-FDOPA PET/CT Findings in a Patient With Primary Cerebral Amyloidoma.

Authors :
Rozenblum L
Bertaux M
Bielle F
Ollivier M
Choquet S
Garcilazo Y
Mokhtari K
Kas A
Source :
Clinical nuclear medicine [Clin Nucl Med] 2020 Apr; Vol. 45 (4), pp. e206-e207.
Publication Year :
2020

Abstract

Amino acid PET, including F-FDOPA, is recommended for initial characterization, delineation of tumor extent, and follow-up of gliomas because of its high diagnostic performances. F-FDOPA accumulates inside tumor cells via the L-type amino acid transporter 1 (LAT1) whose expression is increased in gliomas. We report here a case of a histopathologically proven brain amyloidoma that was first addressed for a suspected glioma. Congo red staining showed scattered extracellular deposits of amyloid and immunohistochemistry-highlighted LAT1 expression, explaining the high F-FDOPA uptake found in this lesion. This case indicates that differential diagnosis of the F-FDOPA uptake in brain lesions should include amyloidoma.

Details

Language :
English
ISSN :
1536-0229
Volume :
45
Issue :
4
Database :
MEDLINE
Journal :
Clinical nuclear medicine
Publication Type :
Academic Journal
Accession number :
32049735
Full Text :
https://doi.org/10.1097/RLU.0000000000002959